$9.48
+0.84%Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Chief Business Development Officer
Chief Executive Officer & Director
Compensation
$1,281,448
Chief Financial Officer
Compensation
$543,483
Chief Medical Officer & Director
Compensation
$298,930
Chief Operating Officer & Director
Compensation
$1,098,149
General Counsel & Corporate Secretary
Compensation
$585,659
President
Compensation
$1,112,528
Vice President of Sales
Compensation
$553,003
During the last 12 months, insiders have sold $2.20M worth of VMD shares, with no buying activity reported.
0
0.00
136.8K
1.24M
-1.2M
-$1.24M
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
0
0.00
233.9K
959.09K
-959K
-$959K
No buying activity
Moore Michael
Officer: President
$1.84M
Kaushal Nitin
Director
$331K
Cambre Jerome
Officer: Vice President Of Sales
$24K
Strong bearish signal with $2.20M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
3 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
VMD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | April 22, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 25, 2025 | April 25, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 26, 2024 | April 26, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 28, 2023 | April 28, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 29, 2022 | April 29, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 30, 2021 | June 10, 2021 | 2021 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.